ASTELLAS PHARMA INC.

Astellas Pharma (4503.T) gains 2.3% as strong trading volume and a high‑margin pipeline in urology, oncology, and metabolic disease reinforce investor confidence.

Explore Astellas Pharma’s latest market snapshot, IDWeek 2026 pipeline highlights, and key share movements – discover what’s driving this Japanese pharma leader.